Registration
Plenary Lecture 2
Cancer Therapy
Latest developments in the treatment of melanoma
Coffee break and Poster viewing
Symposium 3a:
Tumor Immunology
The tumor antigenic landscape associated with T cell infiltration and immunoediting
The role of the lymphatics in cancer checkpoint blockade immunotherapies
Preclinical development of next generation cancer vaccines and immune-enhancers
Symposium 3b:
Type 2 Inflammation and Allergy
What we can learn from allergen-specific immunotherapy for vaccination against COVID-19
Novel concepts in allergy
Clinical or laboratory biomarkers for monitoring AIT
Symposium 3c:
Novel biologics in immunotherapy
On the role of IL-1alpha in disease
IgE-based immunotherapy of cancer
Future therapies and treatment modalities for chronic inflammation
Lunch break with industry exhibition and Poster viewing
Guided Poster tour 2
Company Symposia
Plenary Lecture 3
Pandemics
A brief history of pandemics
Plenary Lecture 4
Monoclonal Antibodies
Using monoclonal antibodies to explore infectious diseases
Room Change
Short Communication Session II
Coffee break and Poster viewing
Symposium 4a:
Microbiota and Immune response
Eosinophil subsets in intestinal inflammation
Exploring the balance of the intestinal flora
Innate mucosal immune responses dictating the course of Salmonella gut infection
Symposium 4b:
Inflammation and therapeutic vaccination
VLP-based therapeutic vaccines in horse allergy
Vaccinating companion animals against chronic diseases
The next generation virus-like particle platform for the treatment of peanut allergy: from bench-to-bedside
Symposium 4c:
Immunity against infection
On the role of IL-1a in disease
The double-edged sword of neutrophils in infectious diseases
Using machine learning to predict vaccine epitopes
Room Change
Closing & Award Ceremony